content

Centrexion eyes the IPO to fund its phase 3 clinical trial

In its attempt to list on the NASDAQ, Centrexion Therapeutics has restarted the effort of going public yet again. The biotech company through the...

Dr. Reddys launches Heartburn Drug in the US

Dr. Reddy’s has launched over-the-counter Heartburn drug called Lansoprazole delayed-release capsules in the US Market. The company has come up with these capsules in...

Moving Pharma Forward – In pursuit of predictability

ITC Maratha - Mumbai, India - 13th September 2019 - In its pursuit of predictability, Envirotainer, the global market leader in secure cold chain...

The increasing importance of failure in supporting modern research

Digital Science has launched a report focusing on falsifiability and reproducibility in scientific research. The report addresses three areas including appropriate documentation and sharing...

Sygnature Discovery develops AR molecular visualisation prototype

The space occupied by a drug molecule in three dimensions, and how it fits into the target, is an important consideration when designing a...

Huge boom in Korean Pharma reported at CPhI Korea

The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across...

QVigilance announces preferred partnership agreement with ESMS Global

QVigilance, a global provider of pharmacovigilance (PV) and risk management services, has announced a preferred partnership agreement with medical information (MI) provider ESMS Global. QVigilance...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read